GlassScriptPhysician profile
Richard Ospina
NPI 1477658730
$18,433.61
in general payments reported to CMS, 2019-2025
58 companies · $2,770 in 2025
The $2,770 reported for 2025 was more than what 78% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,588 · 2020: $3,302 · 2021: $2,945 · 2022: $2,962 · 2023: $1,489 · 2024: $2,378 · 2025: $2,770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,623 · Education: $13.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,623.21 |
| Education | $13.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,159.87 | 2021-2025 | |
| Ucb, INC. | $1,607.02 | 2019-2025 | Fintepla, Nayzilam, Briviact |
| Livanova USA, INC. | $1,439.19 | 2020-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Supernus Pharmaceuticals, INC. | $1,165.35 | 2019-2025 | Qelbree, Qelbree |
| Lilly USA, LLC | $940.53 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Novartis Pharmaceuticals Corporation | $779.63 | 2019-2025 | |
| Eisai INC. | $724.72 | 2019-2025 | |
| Mdd US Operations, LLC | $581.74 | 2022-2025 | Gocovri, Gocovri |
| Sk Life Science, INC. | $537.92 | 2020-2025 | |
| Amgen INC. | $524.51 | 2019-2025 | |
| Biogen, INC. | $511.68 | 2019-2025 | Leqembi, Skyclarys, Spinraza |
| Lundbeck LLC | $488.29 | 2019-2025 | Vyepti |
| Allergan, INC. | $471.21 | 2019-2022 | |
| Genzyme Corporation | $430.71 | 2019-2023 | |
| Otsuka America Pharmaceutical, INC. | $408.38 | 2023-2025 | Rexulti, Nuedexta |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Ospina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.